| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | -$29K | — | -101.0% |
| R&D Expense | $108.9M | — | -8.2% |
| SG&A Expense | $23.3M | — | -2.5% |
| Operating Income | -$132.3M | — | +5.2% |
| Pre-tax Income | -$125.5M | — | -3.8% |
| Income Tax | $170K | — | +962.5% |
| Net Income | -$125.7M | — | -3.9% |
| EPS (Basic) | -$0.85 | — | +3.4% |
| EPS (Diluted) | -$0.85 | — | +3.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $274.2M | +18.1% | +0.2% |
| Short-term Investments | $196.3M | -14.2% | -62.1% |
| Current Assets | $523.0M | +1.7% | -43.9% |
| Total Assets | $1.03B | +2.3% | -21.6% |
| Current Liabilities | $73.6M | -20.7% | -46.4% |
| Total Liabilities | $212.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$132.4M | — | -69.5% |
| Capital Expenditures | $390K | — | -76.1% |
| Investing Cash Flow | $11.8M | — | -90.7% |
| Financing Cash Flow | $162.5M | — | — |
| Free Cash Flow | -$132.8M | — | -66.5% |
| -19.4% |
| Stockholders' Equity | $812.8M | +6.2% | -22.1% |